Arcutis Biotherapeutics (NASDAQ:ARQT – Get Free Report) released its quarterly earnings data on Wednesday. Arcutis Biotherapeutics had a negative net margin of 0.57% and a negative return on equity of 1.41%. Arcutis Biotherapeutics Stock Up 4.1%NASDAQ:ARQT traded up $1.07 during trading hours on Wednesday, hitting $27.10. Get Arcutis Biotherapeutics alerts:Wall Street Analyst Weigh InA number of brokerages have recently commented on ARQT. In August 2022, Arcutis received U.S.Further ReadingReceive News & Ratings for Arcutis Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcutis Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.